Results 131 to 140 of about 9,625,606 (401)

Indicators of the quality of life in women with Graves’ disease after radioactive iodine treatment

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2018
Background. The purpose of the research was to evaluate the quality of life in women with Graves’ disease after radioactive iodine therapy. Materials and methods. We have exa­mined 79 women with Graves’ disease after radioactive iodine treatment.
U.Z. Mirzaeva, Kh.R. Gulyamova
doaj   +1 more source

Graves’ Disease [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2007
Rebecca S. Bahn   +2 more
openaire   +4 more sources

Kidney Stone Dissolution By Tetherless, Enzyme‐Loaded, Soft Magnetic Miniature Robots

open access: yesAdvanced Healthcare Materials, EarlyView.
Wireless magnetic robots are developed for kidney stone dissolution. The robots navigate through a urinary tract model from bladder and ureter to renal pelvis with the help of external magnetic fields. The filaments are loaded with urease enzyme which catalyzes urea to carbon dioxide and ammonia, thereby increasing pH to basic regime and supporting ...
Afarin Khabbazian   +15 more
wiley   +1 more source

Orbital Inflammation in Thyroid Eye Disease: Stress Responses and Their Implications

open access: yesStresses
Thyroid Eye Disease (TED) is a debilitating autoimmune condition characterized by significant inflammation of orbital tissues, including the extraocular muscles and adipose tissues.
Tracy Aoun   +2 more
doaj   +1 more source

Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2016
CONTEXT Biotin (vitamin B7) is an essential co-factor for four carboxylases involved in fatty acid metabolism, leucine degradation, and gluconeogenesis. The recommended daily intake (RDI) of biotin is approximately 30 μg per day. Low-moderate dose biotin
M. Elston   +4 more
semanticscholar   +1 more source

Catatony in Graves' disease

open access: yesEuropean Psychiatry, 1998
SummaryWe report a 27-year-old female patient with prior history of Graves' disease and relapsing episodes of tachycardia, hyperpyrexia, muscular rigidity and coma. With the subsequent manifestation of an acute schizophreniform psychotic disorder unresponsive to neuroleptics, the primary syndrome was re-classified as febrile catatony.
Michael Neveling   +3 more
openaire   +3 more sources

Advanced Multipurpose Spectroscopic Nanobio‐Device for Concurrent Lab‐on‐a‐Chip Label‐Free Separation and Detection of Extracellular Vesicles as Key‐Biomarkers for Point‐of‐Care Cardiovascular Disease Diagnostics

open access: yesAdvanced Healthcare Materials, EarlyView.
AIMSPec‐LoC is a novel lab‐on‐a‐chip platform integrating size‐based extracellular vesicle (EVs) separation with label‐free Raman spectroscopy and AI‐powered classification via SKiNET. This high‐throughput, portable system enables real‐time, multiplexed molecular fingerprinting of EVs from biofluids, offering transformative potential for early, non ...
Emma Buchan   +3 more
wiley   +1 more source

Psychiatric complications in Graves’ disease

open access: yesEuropean Thyroid Journal
Background: Mood disorders are common in Graves’ disease despite treatment. The pathogenic mechanisms involved are unknown and so is whether previous psychiatric disease influences these symptoms.
Mats Holmberg   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy